2-Azetidinone → HCID 71252592, compound

HRID 2411837Notes

Reaction equation

HRID 2411837 reaction equation
Br[C:2]1[CH:7]=[CH:6][C:5]([C:8]([N:10]2[CH2:15][CH2:14][N:13]([C:16]3[C:21]([CH3:22])=[CH:20][C:19]([CH3:23])=[CH:18][N:17]=3)[CH2:12][CH2:11]2)=[O:9])=[C:4]([S:24]([CH3:27])(=[O:26])=[O:25])[CH:3]=1.[NH:28]1[CH2:31][CH2:30][C:29]1=[O:32]>>[CH3:22][C:21]1[C:16]([N:13]2[CH2:14][CH2:15][N:10]([C:8]([C:5]3[CH:6]=[CH:7][C:2]([N:28]4[CH2:31][CH2:30][C:29]4=[O:32])=[CH:3][C:4]=3[S:24]([CH3:27])(=[O:26])=[O:25])=[O:9])[CH2:11][CH2:12]2)=[N:17][CH:18]=[C:19]([CH3:23])[CH:20]=1

Participants

3

Reactant 2

HCID 1367212-AzetidinoneHCID 58484505(4-Bromo-2-methanesulfonylphenyl)[4-(3,5-dimethylpyridin-2-yl)piperazin-1-yl]methanone

Product 1

HCID 71252592HCID 71252592, compoundYield 35%

Procedure

Using (4-bromo-2-methanesulfonylphenyl)[4-(3,5-dimethylpyridin-2-yl)piperazin-1-yl]methanone (420 mg) described in Preparation Example 112 and 2-azetidinone (70 mg) and by the reaction and treatment in the same manner as in Example 1, the title compound (144 mg) was obtained.

Sources & evidence

ORD record
ord-4ede0e2172394d9eaf34d43d387e9be9
Source dataset
uspto-grants-2014_08
Patent number
US08816079B2

Reaction notes

Loading…